Jane Street’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Jane Street’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-20,700	Closed	-$157K	–	11183
2022 Q1	$157K	Sell	20,700 -1,500	-7%	-$14.2K	﹤0.01%	9199
2021 Q4	$227K	Sell	22,200 -21,200	-49%	-$270K	﹤0.01%	8628
2021 Q3	$582K	Sell	43,400 -49,800	-53%	-$812K	﹤0.01%	7001
2021 Q2	$2.04M	Sell	93,200 -37,800	-29%	-$840K	﹤0.01%	4302
2021 Q1	$3.15M	Buy	131,000 +81,700	+166%	+$1.9M	﹤0.01%	3155
2020 Q4	$887K	Buy	49,300 +37,300	+311%	+$557K	﹤0.01%	4860
2020 Q3	$139K	Buy	+12,000	New	+$198K	﹤0.01%	6643

Jane Street's GTHX Position: Q3 2024 in Review

Jane Street sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 64,916 shares — an estimated $148K sold.

Jane Street first reported a position in GTHX in Q3 2018 and held it in 17 quarters. The position peaked at $2.88M in Q1 2021. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

Jane Street reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Jane Street sold 64,916 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $148K.
Jane Street first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2018 and held it in 17 quarters.
Jane Street's G1 Therapeutics, Inc. Common Stock position peaked at $2.88M in Q1 2021.
0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.